Quantcast

Latest radiation poisoning Stories

04d87c97826d2c6ace32c1a32b02e2531
2010-05-15 09:25:00

Greenpeace said Friday that it has detected dangerous levels of radioactivity near a salvage yard in New Delhi where a worker was killed last month from radiation poisonings. Seven others were hospitalized. The group said experts sensed radiation 5,000 times above normal levels at the privately owned facility in the city's overcrowded Mayapuri district and nearby areas. "We picked up six hotspots between 65 and 165 feet from the scrap yard, which means radiation has spread into the streets,...

2009-12-21 06:00:00

PRINCETON, N.J., Dec. 21 /PRNewswire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated a Phase 1/2 clinical trial evaluating SGX201, a time-release formulation of oral beclomethasone 17,21-dipropionate (oral BDP), for the prevention of acute radiation enteritis. This study will be supported in large part by a two-year Small Business Innovation...

2009-12-03 15:04:27

Midway Pharmaceuticals plans clinical trials of PEG 15-20 compound in 2010 A non-absorbed, oral co-polymer therapy under development by Midway Pharmaceuticals demonstrated the ability to protect against damage to healthy gastrointestinal tissues and to prevent lethal bacterial infections in animal models of radiation damage. The results suggest the compound, a high molecular weight co-polymer of polyethylene glycol (PEG), may provide a new way to prevent serious GI side effects of radiation...

2009-09-08 06:00:00

PRINCETON, N.J., Sept. 8 /PRNewswire-FirstCall/ -- DOR BioPharma, Inc. (OTC Bulletin Board: DORB) (DOR or the Company), a late-stage biotechnology company, announced today that the National Institutes of Health (NIH) has awarded DOR a Small Business Innovation Research (SBIR) grant to support the conduct of a Phase 1/2 clinical trial evaluating DOR201, a time-release formulation of oral beclomethasone dipropionate (oral BDP), for the prevention of acute radiation enteritis. The award will...

2009-07-10 11:54:43

 Researchers from Boston University School of Medicine (BUSM) and collaborators have discovered and analyzed several new compounds, collectively called the ''EUK-400 series,'' which could someday be used to prevent radiation-induced injuries to kidneys, lungs, skin, intestinal tract and brains of radiological terrorism victims. The findings, which appear in the June issue of the Journal of Biological Inorganic Chemistry, describe new agents which can be given orally in pill form, which...

2009-06-23 11:20:21

Acute hepatic radiation injury could lead to necrosis of hepatocytes, fatty degeneration and hepatic fibrosis. At the present, the gold standard test is liver biopsy. However, this procedure is invasive, uncomfortable for the patients and sometimes results in serious complications. 31P magnetic resonance spectroscopy (MRS) has been used to study liver metabolism in vivo for several years. A research team led by Jian-Shan Mao from Zhejiang University investigated whether changes of 31P MRS in...

2008-11-03 09:00:40

Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Company will present at the Rodman and Renshaw 10th Annual Healthcare Conference in New York City, November 10-12, 2008. The conference will be held at The New York Palace Hotel. Management will be available to meet with investors or licensing partners November 10-11. Michael Fonstein, Ph.D., President and Chief Executive Officer of Cleveland BioLabs, will give a presentation on the Company's lead compounds and development...

2008-10-21 09:00:54

Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Company will present at the 2008 BIO Investor Forum in San Francisco, October 29-31, 2008. The conference will be held at The Palace Hotel in San Francisco. Management will be available to meet with investors or licensing partners October 29-30. Michael Fonstein, Ph.D., President and Chief Executive Officer of Cleveland BioLabs, will give a presentation on the Company's lead compounds and development strategy on October 30, at...

2008-09-23 06:00:13

JOHNSON CITY, Tenn., Sept. 23 /PRNewswire/ -- Studies conducted to date have demonstrated that even though a single, subcutaneous dose of Rx100 is administered some 26 hours after exposure to lethal, whole-body radiation, a relatively high percentage of test animals survive having received no support other than normal food and water (NOTE: Test animals in many survival protocols receive additional supportive care in the form of antibiotics, etc.). "Preliminary studies suggest a wider time...

2008-09-22 15:00:19

Cellerant Therapeutics Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, announced today that it has been awarded a contract valued at $13.5 million dollars from the Biomedical Advanced Research and Development Authority (BARDA) of the Department of Health and Human Services for the development of a treatment for acute radiation syndrome (ARS). Under terms of the contract, Cellerant will receive $3.4...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'